ArticleInternal medicine (Tokyo, Japan)2019

Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.

Hironari Hanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.